algestone acetophenide has been researched along with ethinyl estradiol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angel de Toro, LA; Lavarello, AC; Roncales Mateo, JM; Sagasta, CL; Salas Diaz, R; Wiemeyer, JC | 1 |
| Astrup, T; Brakman, P; Sobrero, AJ | 1 |
| Ashmawy, S; Hefnawi, F; Kamal, I; Moheidin, O; Talaat, M; Younis, N | 1 |
| Hefnawi, F; Kandil, OF; Sabry, I; Wassef, SA; Younis, N | 1 |
| Nour, H; Younis, N; Zaki, K | 1 |
| Ammar, R; El-ganzoury, B; El-mahgoub, S; Fikri, F; Karim, M; Yaseen, S | 1 |
| Lay, CL | 1 |
1 trial(s) available for algestone acetophenide and ethinyl estradiol
| Article | Year |
|---|---|
Multicentred clinical study of the metabolic effect of the monthly injectable contraceptive containing dihydroxyprogesterone acetophenide 150 mg + estradiol enanthate 10 mg.
Topics: Adult; Algestone; Algestone Acetophenide; Analysis of Variance; Ceruloplasmin; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Copper; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Injections; Levonorgestrel; Multicenter Studies as Topic; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin; Testosterone; Transcortin; Triglycerides; White People | 1990 |
6 other study(ies) available for algestone acetophenide and ethinyl estradiol
| Article | Year |
|---|---|
Effects of different systemic contraceptives on blood fibrinolysis.
Topics: Adult; Algestone Acetophenide; Blood Coagulation Tests; Contraceptives, Oral; Estradiol; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Fibrinogen; Fibrinolysis; Humans; Medroxyprogesterone; Mestranol; Middle Aged; Norethindrone; Norethynodrel; Plasminogen; Pregnancy; Pregnanes; Progestins | 1970 |
Blood coagulation and fibrinolysis with an injectable long-acting progestogen-oestrogen contraceptive.
Topics: Algestone Acetophenide; Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Family Planning Services; Fibrinolysis; Physiology; Research | 1970 |
Ovarian changes during and after long term steroid contraceptive therapy.
Topics: Age Factors; Algestone Acetophenide; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Ethinyl Estradiol; Family Planning Services; Genitalia; Genitalia, Female; Histology; Injections; Lynestrenol; Mestranol; Norethindrone; Ovary; Parity; Physiology; Population; Population Dynamics; Time; Time Factors; Urogenital System | 1970 |
Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
Topics: Algestone Acetophenide; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Endocrine System; Estriol; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Injections; Metabolism; Physiology; Research; Steroids | 1971 |
Evaluation of deladroxate as a monthly contraceptive injection.
Topics: Algestone Acetophenide; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Endometrium; Ethinyl Estradiol; Family Planning Services; Injections; Liver; Menstrual Cycle; Menstruation; Ovary; Pregnancy Rate; Reproductive Control Agents | 1971 |
Clinical trial of intramuscular injection as contraceptive compound.
Topics: Algestone Acetophenide; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Health Planning; Injections; Lactation; Patient Dropouts; Physiology; Pregnancy; Research | 1970 |